Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · May 20, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a treatment called deep brain stimulation (DBS) impacts attention and visual skills in people with Parkinson's disease, particularly those who experience freezing of gait (FOG). FOG is when a person suddenly feels like their feet are glued to the ground, making it difficult to walk. The study aims to understand how problems with visual attention might relate to FOG, especially since some research suggests that stimulating the right side of the brain may help improve this issue.
To participate in the trial, individuals need to be over 18 years old and have undergone bilateral STN-DBS surgery for their Parkinson's disease. However, people with uncorrected vision or hearing problems, those who are pregnant, or individuals with dementia or brain issues that affect thinking or movement cannot take part. If eligible, participants can expect to contribute to important research that may help improve treatments for FOG, as well as gain insights into their own condition. The study is currently recruiting participants of all genders, ages 65 to 74.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects above 18 years of age
- • Subjects with freezing of gait
- • Subjects with bilateral STN-DBS surgery as part of their clinical care for Parkinson's disease
- Exclusion Criteria:
- • Uncorrected visual or hearing impairments, as indicated by self-report
- • Individuals who are pregnant or expect to become pregnant during the course of the study
- • Individuals with dementia or relevant brain lesions impacting cognition or gait
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Nathan DeTurk, MD
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported